New treatment for inoperable pancreatic cancer form offers hope. Here's what Optune Pax does.
Briefly

New treatment for inoperable pancreatic cancer form offers hope. Here's what Optune Pax does.
"The mass was the size of a golf ball, and it was on the head of the pancreas,"
"The itchiness was a blessing in disguise. It gave me an early warning signal something was wrong."
"For cells that are not dividing rapidly, there is no effect on it. It only really effects those that are actively trying to make more copies of themselves - cancer,"
The FDA approved Optune Pax, the first new treatment for inoperable pancreatic cancer in 30 years, after expedited review in 2024. The wearable at-home device delivers electric fields that disrupt dividing cancer cells while sparing nondividing cells. The device is worn up to 18 hours a day and is already used for brain and lung cancers. In clinical trials for locally advanced pancreatic cancer, patients lived about two months longer on average and experienced significantly delayed pain. The device will be available to patients with inoperable disease as research continues for other cancer types. An unusual symptom like itching can sometimes provide an early warning for pancreatic tumors, enabling curative surgery when caught early.
Read at Cbsnews
Unable to calculate read time
[
|
]